Compare TNYA & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNYA | SKIN |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.5M | 123.9M |
| IPO Year | 2021 | 2020 |
| Metric | TNYA | SKIN |
|---|---|---|
| Price | $0.77 | $0.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $5.33 | $2.03 |
| AVG Volume (30 Days) | ★ 2.8M | 551.2K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.96 | ★ 55.56 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $300,790,000.00 |
| Revenue This Year | N/A | $0.98 |
| Revenue Next Year | N/A | $4.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.36 | $0.76 |
| 52 Week High | $2.35 | $2.69 |
| Indicator | TNYA | SKIN |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 47.63 |
| Support Level | $0.64 | $0.87 |
| Resistance Level | $0.82 | $1.22 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 90.88 | 82.08 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.